abstract: Here we report the outcomes of 26 patients who relapsed following conservative surgical treatment of stage I serous borderline ovarian tumours treated initially with fertility-sparing surgery. All recurrences were diagnosed by systematic ultrasonography during follow-up. Eleven patients relapsed at least twice after such management. Twenty-one pregnancies were observed in 13 patients. Eleven of these patients became pregnant after the treatment of their first recurrence. All patients had a borderline ovarian tumour and/or non-invasive peritoneal implants at the time of the first recurrence but two of them had invasive ovarian and peritoneal disease at the time of the second or third recurrence (one of them died of disease). Fertility-preserving surgery remains a valuable alternative (if technically feasible), in young patients with recurrent SBOT, in the form of a non-invasive ovarian lesion, who wish to start a pregnancy. However, it should be associated with meticulous follow-up because the risk of progression to carcinoma exists, albeit small.
Introduction
One-third of borderline ovarian tumours (BOT) are observed in patients ,40 years old in whom the standard method of care remains conservative surgical management of the uterus and preservation of at least a part of one ovary enabling subsequent fertility (Daraï et al., 2013) . The use of conservative surgery increases the risk of recurrence but several retrospective studies suggest that this treatment has no impact on survival because most recurrences were borderline disease with an excellent prognosis (Zanetta et al., 2001) . The option of conservative treatment of recurrent BOT is important in order to promote subsequent fertility. Nevertheless, in the literature, there is only one very short series (six cases) on conservative management of such recurrences (Cheng et al., 2009) . The aim of the present paper is to report a series of 26 cases of conservative treatment of BOT. We focused the study on serous BOT (SBOT) because the risk of tumour bilaterality is more frequent in SBOT than in mucinous tumours (Koskas et al., 2011) . Ipsi and/or contralateral recurrences occur frequently, particularly in SBOT (Koskas et al., 2011) . Patients with SBOT and peritoneal implants (stage II or III disease) were excluded from the present study because the indication for a conservative approach remains controversial (Uzan et al., 2010) .
Patients
From July 1999 to November 2009, 119 patients treated at or referred to the Institut Gustave Roussy after conservative treatment of a stage I SBOT at initial management and with follow-up data were reviewed. Conservative treatment was defined as a uterus-preserving surgical procedure and salvaging of at least a portion of one ovary to allow subsequent fertility. The histopathological review of the ovarian tumour (and peritoneal implants in case of a peritoneal recurrence) was performed by the same pathologist using World Health Organization criteria (Tavassoli and Devilee, 2003) . Among those 119 patients, 38 had relapsed and 26 of them had undergone conservative treatment for their recurrence(s). These 26 patients constitute our case series. Staging was according to the 1987 FIGO classification (International Federation of Gynaecology and Obstetrics). The stage was recorded based on the surgeon's description during the procedure and on a review of the pathology records.
Patient characteristics and oncological results
The characteristics of our 26 patients are detailed in Table I . In addition, three patients had previous history of infertility before the management of their ovarian disease (two of them treated using ovarian stimulation or hyperstimulation). The first recurrence was diagnosed on the systematic follow-up ultrasound scan in 13 cases, during ultasonography carried out because pelvic pains in 3 cases, during ultrasonography carried out during the first trimester of a pregnancy in 1 case and during an ultrasonography carried out at the time of an ovarian stimulation in 1 case. In one patient the recurrence was diagnosed during surgery. In seven cases this information is unknown. Among 12 patients for whom the CA 125 level was known, 1 had abnormal level at the time of the recurrence.
Concerning the initial pathological characteristics of patients, five had stromal microinvasion and two micropapillary patterns (one of them having both components). Five of these patients had only one recurrence but the patient having both components had two recurrences (including one invasive). The histological characteristics of the first ovarian recurrence demonstrated an SBOT in all cases, associated in two patients with a micropapillary pattern not diagnosed during the initial treatment of the ovarian disease.
Eleven patients had a further relapse after the conservative treatment of their recurrence and four of these went on to suffer a third recurrence. The characteristics of patients having two or three recurrences are detailed in Table II .
The surgical procedures during initial treatment of the ovarian tumour and the recurrences are detailed in Table 1 and Fig. 1 . All patients except one had an ovarian recurrence at the first relapse (one had a recurrence in the form of non-invasive peritoneal implants). All of the first recurrences were non-invasive (borderline ovarian disease in 25 and/or noninvasive peritoneal implants in 3).
However, two patients had invasive disease at the second or third ovarian and/or peritoneal recurrence. One patient (without micropapillary patterns or stromal microinvasion), who had relapsed in the form of invasive disease, had a previous history of infertility (treated with ovarian induction). She had undergone an adnexectomy for a stage IA unilateral tumour. She relapsed 4 years later in the form of borderline ovarian disease and had undergone a laparoscopic cystectomy followed by an IVF procedure because of persistent infertility. For the second recurrence, an oophorectomy had been performed on the remaining ovary with resection of non-invasive peritoneal implants for a borderline ovarian tumour. Eight years later, she developed a third recurrence in the form of invasive peritoneal disease. This patient died 2 years after this last recurrence. The second invasive recurrence occurred in a patient with micropapillary patterns and stromal microinvasion who had undergone laparoscopic bilateral cystectomies for SBOT. Six months later she had undergone second-look surgery which revealed non-invasive peritoneal implants. Four years after the first surgical management, she relapsed with an invasive serous grade 1 ovarian carcinoma and peritoneal lesions that were treated radically. She is currently disease free.
Fertility results
Four patients were infertile before the treatment of their ovarian tumour (two of them were receiving infertility therapy). These cases included the oldest patient in this series who was infertile when she had undergone surgery for her ovarian tumour at the age of 43.
Six patients did not desire a pregnancy at the time of the publication. Overall, 21 pregnancies were achieved in 13 patients (17 spontaneous and 4 after IVF or ovarian stimulation) after initial treatment of the ovarian borderline tumour. Among them, six pregnancies in three patients (five spontaneous and one after IVF) were observed before the occurrence of the first recurrence (five with normal outcomes and one ectopic pregnancy). Two of these patients having one pregnancy before the recurrence were also pregnant after the conservative treatment of their recurrence. Details about the fertility results observed after the conservative treatment of the recurrent disease (15 pregnancies in 13 patients) are given in Fig. 2 .
Discussion
This case series is the first paper, after the short series reported by Cheng et al., dedicated to patient outcomes after conservative surgical treatment of recurrent BOT. (Cheng et al., 2009 ). In the paper by Cheng et al. (2009) six cases were reported (with one subsequent recurrence) and no death. Three pregnancies were achieved. Apart from this paper, to our knowledge, there are no other data on fertility-preserving surgery in this particular setting.
The first interesting result in the current series is the feasibility of conservative treatment of ovarian recurrences. Among 119 patients who had undergone conservative treatment for stage I SBOT, 38 relapses were observed. Twenty-six patients (68%) had been treated conservatively for the first recurrence. The first surgical option was then an ultraconservative approach (cystectomy) aimed at promoting subsequent fertility (Palomba et al., 2010 ). An adnexectomy should be reserved for massive involvement of the ovarian parenchyma when it is impossible to preserve healthy ovarian tissue (Palomba et al., 2010) . When an adnexectomy is required for such 'massive' involvement of the parenchyma, ovarian cryopreservation could be then discussed (Fain-Kahn et al., 2009 ). This procedure was performed in four cases in the present series. Nevertheless, the fertility outcomes (and safety after reimplantation of ovarian fragments) of such a strategy are needed to be confirmed.
Concerning our oncological results, two invasive recurrences (one patient succumbing to her recurrence) were observed in the present series. These cases are exceptional in stage I SBOT: the expected incidence is ,0.5% as demonstrated in a recent review of the literature including a meta-analysis (Daraï et al., 2013) . Longacre et al. reported a case similar to ours in a young patient, 48 months after fertility-sparing surgery for a stage I SBOT (Longacre et al., 2005) . She had been treated for a non-invasive ovarian and peritoneal recurrence. She relapsed 24 years later in the form of peritoneal disease. The patient was alive (with persistent disease) at the time of the publication (Longacre et al., 2005) .
Nevertheless, an invasive recurrence (and deaths) could also occur exceptionally in patients with a similar tumour treated with radical surgery (Trimble et al., 2002) . It is therefore not possible to affirm that such cases are linked to fertility-sparing surgery or to the natural history of the tumour. In our two invasive recurrences, these events occurred after conservative management of a first non-invasive recurrence (peritoneal in the first patient in the form of non-ivasive implants and ovarian in the second patient, in the form of a borderline tumour). Perhaps the conservative management of the first recurrence could be questioned in these two cases. Yet, among 26 relapsing patients, 24 had a 'benign' recurrence in the form of a borderline ovarian tumour and/or non-invasive peritoneal implants. Furthermore, among 13 patients who achieved at least 1 pregnancy, 12 became pregnant after conservative treatment of their first recurrence. This signifies that if radical treatment had been performed for the first recurrence in the present series, only one patient would have become pregnant. The use of conservative surgery should therefore be recommended despite a relapse, provided it is non-invasive, to promote subsequent fertility. The ultraconservative procedure (cystectomy) will then be the optimal option if it ensures total removal of the tumour (Yinon et al., 2007; Palomba et al., 2010) .
But these two invasive recurrences raise also the major question of the definition of a 'high-risk group' of progression to carcinoma in stage I SBOT. This potential 'high-risk' group stage I SBOT could be perhaps defined as patients with micropapillary patterns and/or stromal microinvasion (Daraïet al., 2013) . A large multicentre German series was recently published including 950 BOT (in whom 489 stage I SBOT treated conservatively or radically). The presence of micropapillary patterns and/or stromal microninvasion had no impact on the progression-free survival (Du Bois, 2013) . Nevertheless, in another major paper published by Longacre et al. (2005) were observed in univariate analysis for stage I disease: the presence of micropapillary patterns and the presence of stromal microinvasion. During multivariate analysis, only this later one remained very close to the level of the statistical significant (P ¼ 0.06) (Longacre et al., 2005) .
Basically, the use of a conservative approach is not contraindicated in initial management of stage I SBOT with one of those components (Morice et al., 2012; Daraï et al., 2013) . In present series, five patients had micropapillary patterns and two a stromal microinvasion. These patterns had no influence on the risk of iterative recurrence (four out of five patients with micropapillary patterns had a single recurrence). On the other hand, the only patient exhibiting both components had a further invasive recurrence (during the second recurrence). This could suggest that the use of a fertility-sparing management would remain as a valuable alternative during the initial management of the tumour in a young patient having micropapillary patterns and stromal microinvasion, but would be perhaps questioned at the time of the first recurrence. We need to collect more similar cases, and probably with a longer follow-up than observed in our series, before we have additive contributive data about this hypothesis. Whatever the 'high-risk' group in stage I SBOT, finally turns out to be, our series points out the need of a pathological review of the initial tumour with an expert pathologist before discussion of whether to adopt conservative or radical surgery during the management of a patient where systematic ultrasonography raises a suspicion of recurrent disease.
If technically feasible the use of a conservative strategy thus remains a valuable alternative for patients desiring pregnancy who experience a recurrence of non-invasive stage I SBOT after initial conservative treatment. Fortunately, the rate of invasive recurrences is very low after this strategy but nevertheless this risk exists and could exceptionally compromise subsequent survival. Careful and stringent follow-up is essential after such conservative treatment.
